Randomized Trial on the Effect of Topical Phenytoin on Healing After Fistulotomy
- Conditions
- Anal Fistula
- Interventions
- Procedure: Anal fistulotomy
- Registration Number
- NCT03096522
- Lead Sponsor
- Mansoura University
- Brief Summary
Patients with anal fistula who will undergo anal fistulotomy will be randomized into one of two groups; the first group will receive topical phenytoin therapy postoperatively and the second group will not receive such topical treatment.
- Detailed Description
Patients with anal fistula who will undergo anal fistulotomy will be randomized into one of two groups; the first group will receive topical phenytoin therapy postoperatively and the second group will not receive such topical treatment.
Healing of the wound after fistulotomy will be observed every week and the duration till complete healing will be recorded. The two groups will be compared regarding the mean duration till complete healing and postoperative complications.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 38
- Patients of both genders aging between 18-65 years with primary simple anal fistula (subcutaneous, intersphincteric, or low trans-sphicnteric involving less than 25% of external anal sphincter fibers)
- Patients with high trans-sphincteric, extra-sphincteric, supra-sphincteric, secondary, or recurrent anal fistulas.
- Patients with associated anorectal pathology such as anal fissure, hemorrhoids, rectal prolapse, neoplasm, solitary rectal ulcer, and inflammatory bowel diseases.
- Patients under chronic corticosteriod or immunosuppressive therapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Phenytoin 2% spray Anal fistulotomy Patients undergoing anal fistulotomy with postoperative topical phenytoin therapy Phenytoin 2% spray Phenytoin 2% spray Patients undergoing anal fistulotomy with postoperative topical phenytoin therapy Anal fistulotomy Anal fistulotomy Patients undergoing anal fistulotomy without postoperative topical therapy
- Primary Outcome Measures
Name Time Method Healing 4-8 weeks Complete epithelilization of the fistulotomy wound without persistent external openings or discharge
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mansoura university hospital
🇪🇬Mansoura, Dakahlia, Egypt